The Effects of Patient and Visit Characteristics on Health Outcomes in Knee Osteoarthritis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

220 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-01-29

Study Completion Date

2028-01-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to understand the patient and clinic visit characteristics that affect health outcomes for individuals with knee osteoarthritis (OA) pain using topical diclofenac gel. The main questions it aims to answer are:

* What baseline patient characteristics predict response to topical diclofenac?
* Does patient physiology during the study visit predict response to topical diclofenac?
* Do study visit characteristics predict response to topical diclofenac?

Participants will:

* attend 2 study visits to complete study questionnaires and have blood drawn
* apply topical diclofenac to their knee for 8 weeks
* complete biweekly questions about knee pain and diclofenac use between study visits

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Efficacy and Safety of Diclofenac Sodium Gel (DSG) in Knee Osteoarthritis

NCT00426621

Osteoarthritis of the Knee

COMPLETED PHASE3

Efficacy and Safety of Diclofenac Sodium Gel in Knee Osteoarthritis

NCT00171626

Osteoarthritis

COMPLETED PHASE3

A Study to Characterize Diclofenac's Plasma and Knee Exposure After Application of Diclofenac Gel to the Knee of Subjects With Osteoarthritis That Have a Scheduled Arthroplasty

NCT03497039

Pain

COMPLETED PHASE1

Efficacy and Safety of Diclofenac DDEA 2.32 % in Patient Suffering From Knee Osteoarthritis (OA)

NCT01967550

Osteoarthritis, Knee

COMPLETED PHASE3

Efficacy and Safety of Diclofenac Sodium Gel in Knee Osteoarthritis

NCT00171678

Osteearthritis

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

220 older adults with symptomatic knee OA will attend a single research clinic visit (one of four different types of study visits) with a study clinician. The investigators will video record the visits and measure participant heart rate and skin conductance during the visit. Participants will complete baseline questionnaires immediately prior to the study visit. All participants will receive diclofenac gel (a topical over-the-counter non-steroidal anti-inflammatory drug \[NSAID\]), a guideline recommended treatment for knee OA-related pain at the end of the first study visit. Participants will identify an "index" knee (worst pain, right or left) that they will treat and follow during the study. Between study visit 1 and the 8-week follow-up visit, participants will receive an every other week text message asking them to report on pain and diclofenac use to better understand changes in pain over time. Final questionnaires will be completed at the second study visit at week 8.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Knee Osteoarthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Diclofenac

All study participants receiving topical diclofenac gel 1%. Participants will be instructed to apply 4 grams of the gel to the index knee at least once per day, and up to 4 times per day, for 8 weeks.

Group Type EXPERIMENTAL

Topical Diclofenac gel 1%

Intervention Type DRUG

Topical NSAID

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Topical Diclofenac gel 1%

Topical NSAID

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* English-speaking
* 50 years of age or older
* Radiographically confirmed knee OA of K/L grade 2 or higher within the past 2 years
* Knee pain at least 15 days/month.
* Average worst daily pain 3/10 or higher over a two-week period.

Exclusion Criteria

* Medical contraindication to taking NSAIDs such as: history of coronary artery bypass graft, myocardial infarction, coronary artery stent placement, or stroke within the past 6 months; systolic heart failure with ejection fraction \<45%; chronic kidney disease stage ≥4; severe gastrointestinal bleed or stomach ulcer within the past 6 months; current pregnancy; cirrhosis; currently taking blood thinners (aspirin 81 mg daily is okay); allergy to NSAIDs or aspirin; or any other medical contraindication to using topical NSAIDs.
* Inflammatory arthritis
* Partial or total knee replacement of the index knee
* Recent therapeutic injection of the index knee (less than 12 weeks)
* Planned knee/lower limb surgery during the two-month study period
* Active cancer treatment not in remission or life expectancy less than 6 months
* Inability to provide informed consent (e.g. dementia)
* Current use of topical or oral NSAIDs more than 3 days per week.
* Inability to receive text messages or emails to complete questionnaires between study visits.
* Unable to follow the study protocol.

Minimum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No